China Cord Blood Corporation

Hong Kong, China Founded: 2009 • Age: 17 yrs
Umbilical cord blood stem cell banking services are provided.

About China Cord Blood Corporation

China Cord Blood Corporation is a company based in Hong Kong (China) founded in 2009.. China Cord Blood Corporation operates in a competitive market with competitors including Cryo-Cell, BioLife Plasma Services, Cellcolabs, Lazo de Vida and CryoSave, among others.

  • Headquarter Hong Kong, China
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $65 M (USD), Post-IPO

    Apr 28, 2012

  • Investors
    KKR

    & 1 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of China Cord Blood Corporation

  • Total Funding
  • Total Rounds 2
  • Last Round Post-IPO — $65.0M
  • First Round
  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Apr, 2012 Amount Post-IPO - China Cord Blood Corporation Valuation

investors

KKR
Jun, 2007 Amount Private Equity Round - China Cord Blood Corporation Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in China Cord Blood Corporation

China Cord Blood Corporation has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include KKR and EW Healthcare Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Multiple sectors are invested in by this private equity firm.
Founded Year Domain Location
Growth-stage healthcare companies are invested in by EW Healthcare Partners.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by China Cord Blood Corporation

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - China Cord Blood Corporation

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

China Cord Blood Corporation Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of China Cord Blood Corporation

China Cord Blood Corporation operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cryo-Cell, BioLife Plasma Services, Cellcolabs, Lazo de Vida and CryoSave, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Cord blood and tissue stem cells are stored for preservation.
domain founded_year HQ Location
BioLife Plasma Services collects high-quality plasma and processes it into lifesaving therapies.
domain founded_year HQ Location
Stem cell banking services are provided for the healthcare sector.
domain founded_year HQ Location
Provider of stem cell banking services
domain founded_year HQ Location
Umbilical cord blood stem cells are stored for family use.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about China Cord Blood Corporation

When was China Cord Blood Corporation founded?

China Cord Blood Corporation was founded in 2009.

Where is China Cord Blood Corporation located?

China Cord Blood Corporation is headquartered in Hong Kong, China.

What does China Cord Blood Corporation do?

China Cord Blood Corporation was established in 2009 and is headquartered in Hong Kong, China. Operations are centered in the healthcare sector, where umbilical cord blood stem cells are collected, processed, and stored for potential medical applications. Services include secure banking and preservation for families, with a focus on regenerative medicine potential. The company serves clients primarily in the Asia-Pacific region through its specialized facilities and regulatory compliance framework.

Who are the top competitors of China Cord Blood Corporation?

China Cord Blood Corporation's top competitors include Cryo-Cell, Cellcolabs and Lazo de Vida.

Who are China Cord Blood Corporation's investors?

China Cord Blood Corporation has 2 investors. Key investors include KKR, and EW Healthcare Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available